Best Of: Why companies don't want to list in the UK anymore
Behind the Money
Introduction
This chapter explores the fundraising challenges faced by Amunocor, a British biotech firm, as they turned to US investors for additional funding. It also highlights the positive results from their clinical trial in 2020.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
